The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Notification - Replacement

19 Feb 2019 15:02

RNS Number : 5188Q
PureCircle Limited
19 February 2019
 

The following amendment has been made to the 'Notification of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated with them' released on 11 January 2019 at 09:20 under RNS No. 8779M.

 

The final RSUs upper limit vesting percentage under 'Nature of the transaction (section 4b)' has been changed from 100% to 200%.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

PureCircle Limited (the "Company")

 

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Rakesh Sinha

2

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification /Amendment:

Amendment

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

PureCircle Limited

b)

LEI

213800K2PU757HGDAW11 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Restricted Stock Units ("RSUs") over Ordinary Shares of US$0.10 each in the capital of PureCircle Limited

 

BMG7300G1096

b)

Nature of the transaction

Grant of provisional RSUs, under the Long-Term Incentive Plan ("LTIP")

Subject to the terms of the Company's LTIP and achievement of certain group sales targets, the final RSUs (between 0% and 200% of the provisional RSUs), will vest equally on 1 November over the next four years beginning 2019.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

Nil

 

 

87,340

 

d)

Aggregated information

- Aggregated volume

- Price

 

87,340 RSUs

Nil

e)

Date of the transaction

2019-01-10

f)

Place of the transaction

Outside trading venue

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.

 

Name of officer of issuer responsible for making notification: Kan Siew Mei

 

Date of Notification: 19 February 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEALANFSXNEFF
Date   Source Headline
14th Mar 20117:00 amRNSInterim Results and Investor Conference Call
13th Jan 20117:00 amRNSTrading Statement
15th Dec 201012:00 pmRNSAGM Statement
23rd Nov 20107:00 amRNSAGM Statement
9th Nov 20107:00 amRNSLong term incentive plan: Issue of shares
29th Oct 20107:00 amRNSDirector/PDMR Shareholding
28th Oct 20107:00 amRNSRe Audited accounts
23rd Sep 20108:08 amRNSRe Joint Venture
23rd Sep 20107:43 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSFull Year Results
31st Aug 20107:00 amRNSNotice of Allowance for patent
3rd Aug 20107:00 amRNSStevia Trust Mark marketing campaign
29th Jul 20107:00 amRNSRe Global Quality Leaf Sourcing Strategy
28th Jul 20107:00 amRNSMajor contract wins
27th Jul 20107:00 amRNSInterim Management Statement
27th Jul 20107:00 amRNSProposed Joint Venture
26th Jul 20107:00 amRNSGlobal Sales and Marketing VP appointed
21st Jul 20107:00 amRNSFDA 'No Objection' ruling on new product
25th Jun 201012:02 pmRNSGlobal Stevia Institute announces key members
26th May 20107:00 amRNSLaunch of Global Stevia Institute
5th May 20107:00 amRNSNew products launching at a greater rate
14th Apr 20106:25 pmRNSEFSA evaluates the safety of steviol glycosides
6th Apr 20107:00 amRNSUpdate on New Product Launches
1st Apr 20109:59 amRNSChange of significant Shareholding
30th Mar 201011:18 amRNSIssue of new shares and exercise of options
22nd Mar 20107:00 amRNSHalf Yearly Report
5th Mar 20107:00 amRNSNotice of Results
4th Mar 20107:00 amRNSProduct Launches
26th Feb 20107:00 amRNSManagement changes
22nd Feb 20107:00 amRNSRe Joint Venture
9th Feb 20109:27 amRNSChange of Significant Shareholding
1st Feb 20107:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20107:00 amRNSProduct Launch
14th Jan 20109:09 amRNSRe Agreement
18th Dec 20097:00 amRNSSignificant shareholding
17th Dec 20097:00 amRNSSignificant Shareholders and Notifiable Interest
8th Dec 20099:11 amRNSissue of shares
24th Nov 200910:17 amRNSResult of AGM
23rd Nov 20097:00 amRNSNotifiable Interests
19th Nov 20097:00 amRNSissue of shares
18th Nov 20097:00 amRNSPlacing
16th Nov 20097:00 amRNSPureCircle collaboration with Nestle Malaysia
13th Nov 20097:00 amRNSPureCircle wins major award
11th Nov 20097:00 amRNSExpansion of supply source
6th Nov 20097:00 amRNSProduct Launch
4th Nov 20097:00 amRNSStevia product launches hit 200
2nd Nov 200911:15 amRNSAnnual Financial Report
30th Oct 20097:00 amRNSNotice of AGM
30th Oct 20097:00 amRNSStatement re Collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.